Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


LONG-TERM INSULIN STIMULATION STABILIZED COUP-TFII PROTEIN IN HUMAN ARTERIAL ENDOTHELIAL CELLS (HUAEC)
Abstract number: P22-L3-12

Brunssen1 C, Goettsch1 W, Brux1 M, Seifert1 S, Roesler1 J, Morawietz1 H

1Dept. of Vascular Endothelium and Microcirculation, University of Technology Dresden

The physiological mechanisms leading to the differentiation of blood vessels and the molecular pathophysiology of vessel- specific diseases are currently not well understood. Patients with diabetes have an increased risk of peripheral arterial disease. HEY2 is a stable marker gene for arterial, whereas COUP-TFII is highly expressed in venous endothelial cells. For COUP-TFII, a role in the glucose/insulin metabolism has been suggested in vivo. In order to analyze the underlying mechanism in vitro, HUAECs were maintained in 22.2 mM glucose medium and stimulated in a time (24, 48, 72 h)- and dose (0, 5, 50 nM)-dependent manner with insulin. In these cells, mRNA (by RT-PCR) and protein expression (by Western blot) of HEY2 and COUP-TFII was quantified. HEY2 showed no significant changes in mRNA or protein expression in response to insulin under these conditions. Furthermore, there was no significant impact on COUP-TFII mRNA expression. However, COUP-TFII protein level was increased after 72 h in a dose-dependent manner, compared to time-matched control (control: 100±11%, 5 nM insulin 186±10%, 50nM insulin 238±8%). In conclusion, our data suggest a stabilization of the venous marker protein COUP-TFII in arterial endothelial cells after long-term stimulation with insulin. In contrast, the arterial marker HEY2 did not change.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :P22-L3-12

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE